Kolexia
Beltrand Jacques
Pédiatrie
Hôpital Necker Enfants Malades
Paris, France
177 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Diabète Diabète de type 1 Maladies néonatales Insulinorésistance Hypoglycémie Polydipsie Urgences Polyurie Diabète de type 2

Industries

Lilly
24 collaboration(s)
Dernière en 2023
Sanofi
20 collaboration(s)
Dernière en 2023
Medtronic
13 collaboration(s)
Dernière en 2023
PROVENTION BIO, INC.
4 collaboration(s)
Dernière en 2022

Dernières activités

RADIANT: Randomized Controlled Trial to Demonstrate the Efficacy of the Omnipod® 5 System When Compared to Multiple Daily Injections for Treatment of Type 1 Diabetes (RADIANT)
Essai Clinique (Insulet Corporation)   04 décembre 2023
Glucose pattern in children with classical congenital adrenal hyperplasia: evidence from continuous glucose monitoring.
European journal of endocrinology   21 novembre 2023
Identifying patient-related predictors of permanent growth hormone deficiency.
Frontiers in endocrinology   10 octobre 2023
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.
Nature medicine   05 octobre 2023
Systematic Review of Treatment of Beta-Cell Monogenic Diabetes.
medRxiv : the preprint server for health sciences   22 septembre 2023
PROTECT: Phase 3 Randomized Double-Blind Multinational Placebo-Controlled Study to Evaluate Efficacy and Safety of Teplizumab, a Humanized FcR Non-Binding Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Newly Diagnosed Type 1 Diabetes
Essai Clinique (Provention Bio, Inc.)   23 août 2023
Assessment of Puberty and Hypothalamic-Pituitary-Gonadal Axis Function After Childhood Brain Tumor Treatment.
The Journal of clinical endocrinology and metabolism   21 août 2023
GH and Childhood-onset Craniopharyngioma: When to Initiate GH Replacement Therapy?
The Journal of clinical endocrinology and metabolism   17 juillet 2023
First Generation of a Modular Interoperable Closed-Loop System for Automated Insulin Delivery in Patients With Type 1 Diabetes: Lessons From Trials and Real-Life Data.
Journal of diabetes science and technology   14 juillet 2023
GALOP: Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)
Essai Clinique (Assistance publique – Hôpitaux de Paris)   14 juin 2023